Accenture, Orexo Team to Offer Digital Therapeutics Through INTIENT™ Platform

NEW YORK and MORRISTOWN, N.J.; Nov. 16, 2020 ‒ Accenture (NYSE: ACN) has helped the U.S. subsidiary of Swedish pharmaceutical company Orexo launch its first digital therapeutic, vorvida®, for patients in the United States dealing with problematic alcohol use. vorvida® is a web-based digital platform that uses the INTIENT™ Patient solution suite, which is powered by Google Cloud, to enable secure patient interactions and connectivity to an ecosystem of third-party health care services.

Comments

Popular posts from this blog

Add Custom Field in Output of Standard Report of ME2N

UK to Receive Egyptian LNG Cargo

HANA Housekeeping using HANACleaner